The living kidney donor evaluation: Focus on renal issues

Clinical Journal of the American Society of Nephrology

Volumn 7, Issue 2, 2012, Pages 366-371

  Kher, Ajay ^a   Mandelbrot, Didier A ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE;

AFRICAN AMERICAN; AGE; ALBUMINURIA; ARTICLE; BLOOD PRESSURE; BODY MASS; CARDIOVASCULAR DISEASE; CAUCASIAN; CHRONIC KIDNEY DISEASE; CREATININE CLEARANCE; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DISEASE COURSE; DONOR SELECTION; GENETIC DISORDER; GENETIC RISK; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; HEMATURIA; HIGH RISK PATIENT; HUMAN; HYPERTENSION; KIDNEY DONOR; KIDNEY DYSFUNCTION; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; LIVING DONOR; META ANALYSIS (TOPIC); NEPHROLITHIASIS; OBESITY; POPULATION GENETICS; POSTOPERATIVE COMPLICATION; PREGNANCY DIABETES MELLITUS; PROTEINURIA; RACE DIFFERENCE; TREATMENT OUTCOME; UNINEPHRECTOMY;

DONOR SELECTION; HUMANS; KIDNEY TRANSPLANTATION; LIVING DONORS; NEPHRECTOMY; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84857179566     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.10561011     Document Type: Article

References (47)

1. Najarian JS, Chavers BM, McHugh LE, Matas AJ: 20 years or more of follow-up of living kidney donors. Lancet 340: 807-810, 1992
2. Segev DL, Muzaale AD, Caffo BS, Mehta SH, Singer AL, Taranto SE, McBride MA, Montgomery RA: Perioperative mortality and long-term survival following live kidney donation. JAMA 303: 959-966, 2010
3. Johnson EM, Remucal MJ, Gillingham KJ, Dahms RA, Najarian JS, Matas AJ: Complications and risks of living donor nephrec-tomy. Transplantation 64: 1124-1128, 1997
4. Mjøen G, Øyen O, Holdaas H, Midtvedt K,Line PD: Morbidityand mortalityin1022 consecutive livingdonor nephrectomies: Benefits of a living donor registry. Transplantation 88: 1273-1279, 2009
5. Patel S, Cassuto J, Orloff M, Tsoulfas G, Zand M, Kashyap R, Jain A, Bozorgzadeh A, Abt P: Minimizing morbidity of organ donation: Analysis of factors for perioperative complications after living-donor nephrectomy in the United States. Transplantation 85: 561-565, 2008
6. Narkun-Burgess DM, Nolan CR, Norman JE, Page WF, Miller PL, Meyer TW: Forty-five year follow-up after uninephrectomy. Kidney Int 43: 1110-1115, 1993
7. Fehrman-Ekholm I, Elinder CG, Stenbeck M, Tydén G, Groth CG: Kidney donors live longer. Transplantation 64: 976-978, 1997
8. Ibrahim HN, Foley R, Tan L, Rogers T, Bailey RF, Guo H, Gross CR, Matas AJ: Long-term consequences of kidney donation. N Engl J Med 360: 459-469, 2009
9. Davis CL, Cooper M: The state of U.S. living kidney donors. Clin J Am Soc Nephrol 5: 1873-1880, 2010
10. Reese PP, Feldman HI, McBride MA, Anderson K, Asch DA, Bloom RD: Substantial variation in the acceptance of medically complex live kidney donors across US renal transplant centers. Am J Transplant 8: 2062-2070, 2008
11. Ommen ES, Winston JA, Murphy B: Medical risks in living kidney donors: Absence of proof is not proof of absence. Clin J Am Soc Nephrol 1: 885-895, 2006
12. Young A, Storsley L, Garg AX, Treleaven D, Nguan CY, Cuerden MS, Karpinski M: Health outcomes for living kidney donors with isolated medical abnormalities: A systematic review. Am J Transplant 8: 1878-1890, 2008
13. Mandelbrot DA, Pavlakis M, Karp SJ, Johnson SR, Hanto DW, Rodrigue JR: Practices and barriers in long-term living kidney donor follow-up: A survey of U.S. transplant centers. Transplantation 88: 855-860, 2009
14. Mandelbrot DA, Pavlakis M, Danovitch GM, Johnson SR, Karp SJ, Khwaja K, Hanto DW, Rodrigue JR: The medical evaluation of living kidney donors: A survey of US transplant centers. Am J Transplant 7: 2333-2343, 2007
15. Delmonico F; Council of the Transplantation Society: A report of the Amsterdam Forum on the Care of the Live Kidney Donor: Data and medical guidelines. Transplantation 79[Suppl]: S53- S66, 2005
16. Dols LF, Kok NF, Roodnat JI, Tran TC, Terkivatan T, Zuidema WC, Weimar W, Ijzermans JN: Living kidney donors: Impact of age on long-term safety. Am J Transplant 11: 737-742, 2011
17. Jacobs SC, Ramey JR, Sklar GN, Bartlett ST: Laparoscopic kidney donation from patients older than 60 years. J Am Coll Surg 198: 892-897, 2004
18. Neipp M, Jackobs S, Jaeger M, Schwarz A, Lueck R, Gwinner W, Becker T, Klempnauer J: Living kidney donors.60 years of age: Is it acceptable for the donor and the recipient? Transpl Int 19: 213- 217, 2006
19. Steiner RW: 'Normal for now' or 'at future risk': A double standard for selecting young and older living kidney donors. Am J Transplant 10: 737-741, 2010
20. Gibney EM, King AL, Maluf DG, Garg AX, Parikh CR: Living kidney donors requiring transplantation: Focus on African Americans. Transplantation 84: 647-649, 2007
21. Kampmann J, Siersbaek-Nielsen K, Kristensen M, Hansen JM: Rapid evaluation of creatinine clearance. Acta Med Scand 196: 517-520, 1974
22. Folin O: Laws governing the chemical composition of urine. Am J Physiol 13: 66-115, 1905
23. Rule AD, Gussak HM, Pond GR, Bergstralh EJ, Stegall MD, Cosio FG, Larson TS: Measured and estimated GFR in healthy potential kidney donors. Am J Kidney Dis 43: 112-119, 2004
24. Tent H, Rook M, Stevens LA, van Son WJ, van Pelt LJ, Hofker HS, Ploeg RJ, van der Heide JJ, Navis G: Renal function equations before and after living kidney donation: A within-individual comparison of performance at different levels of renal function. Clin J Am Soc Nephrol 5: 1960-1968, 2010
25. Davies DF, Shock NW: Age changes in glomerular filtration rate, effective renal plasma flow, and tubular excretory capacity in adult males. J Clin Invest 29: 496-507, 1950
26. Gonwa TA, Atkins C, Zhang YA, Parker TF, Hunt JM, Lu CY, White MG: Glomerular filtration rates in persons evaluated as living-related donors-are our standards too high? Transplantation 55: 983-985, 1993
27. Rowe JW, Andres R, Tobin JD, Norris AH, Shock NW: The effectof age on creatinine clearance in men: A cross-sectional and longitudinal study. J Gerontol 31: 155-163, 1976
28. National Kidney Foundation: K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am J Kidney Dis 39[Suppl 1]: S1-S266, 2002
29. Poggio ED, Rule AD, Tanchanco R, Arrigain S, Butler RS, Srinivas T, Stephany BR, Meyer KH, Nurko S, Fatica RA, Shoskes DA, Krishnamurthi V, Goldfarb DA, Gill I, Schreiber MJ: Demographic and clinical characteristics associated with glomer-ular filtration rates in living kidney donors. Kidney Int 75: 1079- 1087, 2009
30. Nordén G, Lennerling A, Nyberg G: Low absolute glomerular filtration rate in the living kidney donor: Arisk factor for graft loss. Transplantation 70: 1360-1362, 2000
31. US Renal Data System: USRDS 2011 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States, Bethesda, MD, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2011
32. Byrne C, Nedelman J, Luke RG: Race, socioeconomic status, and the development of end-stage renal disease. Am J Kidney Dis 23: 16-22, 1994
33. Lentine KL, Schnitzler MA, Xiao H, Saab G, Salvalaggio PR, Axelrod D, Davis CL, Abbott KC, Brennan DC: Racial variation in medical outcomes among living kidney donors. N Engl J Med 363: 724-732, 2010
34. Genovese G, Friedman DJ, Ross MD, Lecordier L, Uzureau P, Freedman BI, Bowden DW, Langefeld CD, Oleksyk TK, Uscinski Knob AL, Bernhardy AJ, Hicks PJ, Nelson GW, Vanhollebeke B, Winkler CA, Kopp JB, Pays E, Pollak MR: Association of trypa-nolytic ApoL1 variantswith kidney disease in African Americans. Science 329: 841-845, 2010
35. Reeves-Daniel AM, DePalma JA, Bleyer AJ, Rocco MV, Murea M, Adams PL, Langefeld CD, Bowden DW, Hicks PJ, Stratta RJ, Lin JJ, Kiger DF, Gautreaux MD, Divers J, Freedman BI: TheAPOL1 gene and allograft survival after kidney transplantation. Am J Transplant 11: 1025-1030, 2011
36. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jones DW, Materson BJ, Oparil S, Wright JT, Roccella EJ; National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood PressureNational High Blood Pressure Education Program Coordinating Committee: The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report. JAMA 289: 2560-2572, 2003
37. Textor SC, Taler SJ, Driscoll N, Larson TS, Gloor J, Griffin M, Cosio F, Schwab T, Prieto M, Nyberg S, Ishitani M, Stegall M: Blood pressure and renal function after kidney donation from hypertensive living donors. Transplantation 78: 276-282, 2004
38. American Diabetes Association: Standards of medical care in diabetes-2011. Diabetes Care 34[Suppl 1]: S11-S61, 2011
39. Hsu CY, McCulloch CE, Iribarren C, Darbinian J, Go AS: Body mass index and risk for end-stage renal disease. Ann Intern Med 144: 21-28, 2006
40. Praga M, Hernández E, Herrero JC, Morales E, Revilla Y, Díaz-González R, Rodicio JL: Influence of obesity on the appearance of proteinuria and renal insufficiency after unilateral nephrectomy. Kidney Int 58: 2111-2118, 2000
41. Heimbach JK, Taler SJ, Prieto M, Cosio FG, Textor SC, Kudva YC, Chow GK, Ishitani MB, Larson TS, Stegall MD: Obesity in living kidneydonors: Clinical characteristics and outcomes in the era of laparoscopic donor nephrectomy. Am J Transplant 5: 1057- 1064, 2005
42. Tavakol MM, Vincenti FG, Assadi H, Frederick MJ, Tomlanovich SJ, Roberts JP, Posselt AM: Long-term renal function and cardiovascular disease risk in obese kidney donors. Clin J Am Soc Nephrol 4: 1230-1238, 2009
43. Springberg PD, Garrett LE Jr, Thompson AL, Collins NF, Lordon RE, Robinson RR: Fixed and reproducible orthostatic proteinuria: Results of a 20-year follow-up study. Ann Intern Med 97: 516- 519, 1982
44. National Kidney Foundation KDOQI clinical practice guidelines and clinical practice recommendations for diabetes and chronic kidney disease: Am J Kidney Dis 49[Suppl 2]: S12- S154, 2007
45. Vivante A, Afek A, Frenkel-Nir Y, Tzur D, Farfel A, Golan E, Chaiter Y, Shohat T, Skorecki K, Calderon-Margalit R: Persistent asymptomatic isolated microscopic hematuria in Israeli adolescents and young adults and risk for end-stage renal disease. JAMA 306: 729-736, 2011
46. Ennis J, Kocherginsky M, Schumm LP, Worcester E, Coe FL, Josephson MA: Trends in kidney donation among kidney stone formers: A survey of US transplant centers. Am J Nephrol 30: 12- 18, 2009
47. Pei Y, Obaji J, Dupuis A, Paterson AD, Magistroni R, Dicks E, Parfrey P, Cramer B, Coto E, Torra R, San Millan JL, Gibson R, Breuning M, Peters D, Ravine D: Unified criteria for ultrasono-graphic diagnosis of ADPKD. J Am Soc Nephrol 20: 205-212, 2009